Healthcare and tech leaders evaluate entrepreneurial ideas in live innovation competition

American Heart Association

DALLAS, November 2, 2022 The American Health Association (AHA) Center for Health Technology & Innovation today announced five finalists for the AHA Health Tech Competition. The finalists are AvoMD (Brooklyn, New York), Bloomer Tech (Boston, Massachusetts), Cipherome (San Jose, California), NimbleHeart (Sunnyvale, California), and Opsis (Golden, Colorado). They will compete live at the Association's Scientific Sessions in Chicago on November 5 and 6, 2022.

These five health start-up finalists will discuss their ideas for using new technologies in the treatment and prevention of cardiovascular disease with a panel of distinguished judges, top physicians and industry leaders. The competition is held at the McCormick Place Convention Center in the Health Innovation Pavilion located in the Heart Hub on Saturday at 1:00 – 2:00 p.m. and Sunday at 11:30 a.m. - 12:30 p.m.

The Association holds the competition to highlight the innovations and market advancements from the health care and technology companies that engage with its Center for Health Technology and Innovation throughout the year.

The presentations will be evaluated on the following criteria:

  • Validity: How well is the working prototype or product functioning in the market with customers?
  • Scientific rigor: How well does the validation research utilize evidence-based health research?
  • Impact: To what extent does the product improve patient outcomes through innovative technology?

The winner will receive a membership to AHA's Center for Health Technology & Innovation Innovators Network, a consortium that connects entrepreneurs, providers, researchers and payers. Innovators' Network members also have access to the Association's digital guidelines, recommendations and best-in-class science as they develop digital healthcare technologies.

Members participate with the Center in different ways, including building models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.

Volunteer judges from the health care and technology fields will evaluate the impact and business case around the proposals, as well as present the impact on science and the evidence of health and patient impact in two separate evaluations. Winners will be announced on Sunday, November 6, 2022 at 1 p.m. Central Time.

Judges include Eric Peterson, M.D. of University of Texas, Southwestern (Dallas); Lee Shapiro of 7wire Ventures (Chicago); Heather Provino of The Scanlon Group (East Greenwich, Rhode Island); Asif Ali, M.D. of Memorial Hermann Hospital (Houston); Seth Martin, M.D. of Johns Hopkins University (Baltimore); Azizi Seixas, PhD of the University of Miami (Miami); Anekwe Onwuanyi, M.D. of the Association of Black Cardiologists/ Moorehouse School of Medicine (Atlanta); Neil Patel of Redesign Health (New York); Animesh Aashoo Tandon of Cleveland Clinic (Cleveland); Robert A Harrington, M.D. of Stanford University (Stanford, California); Tiffany M Powell-Wiley, M.D. of the National Institutes of Health (Bethesda, Maryland.); Ann Marie Navar, M.D. of University of Texas, Southwestern (Dallas), and Mike McConnell, MD of Tesseract (Guilford, Connecticut).

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.